97 related articles for article (PubMed ID: 1990613)
1. The involvement of platelet-activating factor in hyperacute xenogeneic rejection and its modulation by the PAF-antagonist WEB 2086BS.
Saumweber DM; Bergmann R; Gokel M; Brecht HM; Hammer C
Transplant Proc; 1991 Feb; 23(1 Pt 1):576-8. PubMed ID: 1990613
[No Abstract] [Full Text] [Related]
2. Studies on xenograft rejection: the role of leukocytes and prostaglandins and their modulation by the hetrazepine WEB 2086BS.
Saumweber DM; Bergmann R; Gokel M; Zellner C; Brecht HM; Hammer C
Transplant Proc; 1992 Apr; 24(2):578-80. PubMed ID: 1566436
[No Abstract] [Full Text] [Related]
3. Hyperacute rejection in an ex vivo model of renal xenografting. Role of the mediator response and its pharmacologic manipulation by the specific platelet-activating factor antagonist WEB 2086BS.
Saumweber DM; Bergmann R; Gokel M; Hammer C
Transplantation; 1994 Feb; 57(3):358-63. PubMed ID: 8108870
[TBL] [Abstract][Full Text] [Related]
4. Effects of a PAF-antagonist (WEB 2086) on hyperacute xenogeneic rejection in ex vivo perfused kidneys.
Bergmann R; Saumweber DM; Brecht HM; Hammer C
Transplant Proc; 1990 Aug; 22(4):2009-10. PubMed ID: 2389511
[No Abstract] [Full Text] [Related]
5. Survival of renal allografted dogs after limited therapy with cyclosporine and the PAF antagonist WEB 2170.
Metcalfe SM; Watson CJ; Collier DG; DaCosta M; Friend PJ; Pollard SG; Luddington R; Calne RY
Transplant Proc; 1991 Aug; 23(4):2219-20. PubMed ID: 1871852
[No Abstract] [Full Text] [Related]
6. Prolongation of rat heart allograft survival using low-dose cyclosporine and PAF antagonist WEB 2170.
Da Costa M; Metcalfe S; Calne RY
Transplant Proc; 1990 Aug; 22(4):1945-6. PubMed ID: 2389490
[No Abstract] [Full Text] [Related]
7. Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits.
Yue TL; Farhat M; Rabinovici R; Perera PY; Vogel SN; Feuerstein G
J Pharmacol Exp Ther; 1990 Sep; 254(3):976-81. PubMed ID: 2395125
[TBL] [Abstract][Full Text] [Related]
8. Xenoperfusion of rabbit kidney and the impact of BN 52021: a specific antagonist of platelet-activating factor.
Otte KE; Jørgensen KA; Bonnevie V; Barfort P; Larsen S; Starklint H; Pirotzky E; Kemp E
Transplant Proc; 1990 Jun; 22(3):1089-90. PubMed ID: 2349668
[No Abstract] [Full Text] [Related]
9. [Involvement of platelet activating factor (PAF) in ovalbumin antigen-induced late asthmatic response and increase of airway hyperresponsiveness in a guinea pig experimental model of asthma].
Arima M; Yukawa T; Terashi Y; Sagara H; Makino S
Arerugi; 1991 Feb; 40(2):141-6. PubMed ID: 2069513
[TBL] [Abstract][Full Text] [Related]
10. The pathophysiological role of PAF in anaphylactic lung reaction in the guinea pig and in endotoxin shock evidenced by the specific PAF-antagonist WEB 2086.
Heuer H; Casals-Stenzel J
Prog Clin Biol Res; 1989; 308():925-30. PubMed ID: 2675077
[No Abstract] [Full Text] [Related]
11. Inhibition of the release of prostaglandins, thromboxanes, and leukotrienes from anaphylactic lungs by a platelet-activating factor (PAF) antagonist and its stimulation by PAF.
Sirois P; Harczy M; Braquet P; Borgeat P; Maclouf J; Pradelles P
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1033-7. PubMed ID: 2823554
[No Abstract] [Full Text] [Related]
12. [PAF receptor antagonist in asthma therapy].
Sagara H; Makino S; Fukuda T
Nihon Rinsho; 1996 Nov; 54(11):3056-61. PubMed ID: 8950954
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic heart transplantation following xenografting.
Pratschke J; Breuer M; Hammer C; Schütz A; Kemkes BM; Engelhardt M; Brandl U; Saumweber D; Babic R; Reichart B
Transplant Proc; 1992 Apr; 24(2):688-90. PubMed ID: 1566482
[No Abstract] [Full Text] [Related]
14. Effects of platelet-activating factor on coronary hemodynamics and coronary venous plasma levels of TXB2, 6-keto-PGF1 alpha, and leukotriene C4 immunoreactivity in the intact domestic pig heart.
Ezra D; Feuerstein G; Ramwell PW; Hayes E; Goldstein RE
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():19-21. PubMed ID: 3159202
[No Abstract] [Full Text] [Related]
15. Early cellular rejection of pig kidney perfused with manipulated human blood to avoid hyperacute rejection.
Vega A; Ramos A; Val F; López-Hoyos M; Ruiz JC; de Francisco AL; Castillo J; Fleitas MG; Arias M
Transplant Proc; 1999 Sep; 31(6):2643-4. PubMed ID: 10500756
[No Abstract] [Full Text] [Related]
16. Histologic and ultrastructural changes after large-colon torsion, with and without use of a specific platelet-activating factor antagonist (WEB 2086), in ponies.
Wilson DV; Patterson JS; Stick JA; Provost PJ
Am J Vet Res; 1994 May; 55(5):681-8. PubMed ID: 8067617
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
[TBL] [Abstract][Full Text] [Related]
19. Interactions of prostanoids with the platelet activating factors.
Mentz P; Mentz G; Giessler C; Mest HJ
Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):13-6. PubMed ID: 1279731
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
